This is a single-blind randomized clinical trial. Patients undergoing abdominal tumor surgery were recruited to participate in the study. Apart from routine treatment in the surgical intensive care unit, the subjects were randomly divided into two groups: Propofol group (Group P) and Dexmedetomidine group (Group D) and received continuous intravenous infusion of Propofol (infusion dosage range: 0.3 \~ 1.6 mg/kg/h) or Dexmedetomidine (infusion dosage range: 0.1 \~ 0.7 mcg/kg/h) according to their assigned group. Patients' hemodynamic status was monitored using a chest Bioreactance technique, Continuous Non-Invasive Cardiac Output and Hemodynamic Monitor at preset time points (time of recruitment \[0h\], 2, 4, 6, 12h and 24h). Clinical data such as vital signs, hemodynamic parameters, laboratory results, fluid volume and drugs used were also recorded.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
Sedation
Sedation
National Taiwan University Hospital
Taipei, Taipei, Taiwan
cardiac index
the cardiac index measured by the Bioreactance-based noninvasive CO measurement (NICOM system) six hours after recruitment
Time frame: six hours after recruitment
mean arterial pressure
Time frame: six hours after recruitment
heart rate
Time frame: six hours after recruitment
stroke volume
Time frame: six hours after recruitment
urine output
Time frame: six hours after recruitment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.